UnitedHealth Group stock gains as investors weigh higher outlook
Published on 11/10/2026 at 16:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSA firmer quote, unchanged earnings focus
- UnitedHealth Group stock trades above the quote published on Monday, November 9.
- Investors continue to weigh the higher 2026 adjusted earnings floor against medical-cost and execution risks.
UnitedHealth Group stock traded at 356.90 euros on Lang & Schwarz at 16:36 CET on Tuesday, November 10, 2026, 0.93 percent above the Xetra close of 353.60 euros from Monday, November 9. The quote was 1.02 percent higher than the 353.30-euro level in the previous report published on Monday at 17:04 CET, a separate comparison with the earlier report.
Higher outlook, continuing execution test
The previous report said UnitedHealth Group had lifted its adjusted 2026 earnings floor after third-quarter results reported on October 13. It cited adjusted earnings of at least 20.50 US dollars per share, third-quarter revenue of 112.7 billion US dollars and operating earnings of 6.6 billion US dollars.
That outlook leaves medical-cost control, pricing discipline and care-delivery execution as the main operating questions for investors. The earlier report also highlighted quarterly operating cash flow of 5.1 billion US dollars and a debt-to-capital ratio of 41.7 percent at September 30 as benchmarks for the recovery.
Market reference and company profile
The FAZ market page lists the November 9 Xetra close at 353.60 euros and identifies UnitedHealth Group as a US healthcare company offering health insurance, healthcare technology and pharmacy benefit management.
UnitedHealth Group market facts
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Home exchange: New York Stock Exchange
- Lang & Schwarz quote: 356.90 euros at 16:36 CET on November 10, 2026
- Change versus previous report: 1.02 percent above 353.30 euros on November 9, 2026
- Xetra close: 353.60 euros on November 9, 2026
- 52-week range: 222.70 to 400.60 euros
Broader US equities remain the relevant market backdrop for UnitedHealth Group stock, with the S&P 500 providing the main market reference.
